Table 5.
Multivariate analysis of overall survival
Covariate | HR | 95% Cl | p-value |
---|---|---|---|
NDRF0 vs NDRF2 or 3 | 1.579 | 1.118–2.334 | 0.0013* |
Age, ≤70 y vs ≥71 y | 0.914 | 0.632–1.315 | 0.3146 |
Female vs. male | 0.529 | 0.375–0.812 | 0.0011* |
Non smokers vs smoker | 1.028 | 0.679–1.536 | 0.7649 |
ECOG PS 0–2 vs. 3–4 | 0.374 | 0.217–0.534 | <0.0001* |
Non-sq vs. sq | 0.593 | 0.296–0.975 | 0.0039* |
Stage IIIb vs IV | 0.582 | 0.413–0.872 | 0.0416* |
Notes:
p<0.05. NDRF0: no high level of above markers; NDRF2: no fewer than two high levels of above markers; NDRF3: all high levels of above markers.
Abbreviations: NDRF, newly designed risk factor; ECOG, Eastern Cooperative Oncology Group; PS, performance status; sq, squamous cell carcinoma; HR, hazard ratio; CI, confidence interval.